• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌胰腺转移瘤与富血供神经内分泌肿瘤的鉴别:相对百分比洗脱值的应用及其临床意义。

Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.

作者信息

Kang Tae Wook, Kim Seong Hyun, Lee Jisun, Kim Ah Yeong, Jang Kyung Mi, Choi Dongil, Kim Min Ji

机构信息

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Ilwon-Ro, Gangnam-gu, Seoul 135-710, Republic of Korea.

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Ilwon-Ro, Gangnam-gu, Seoul 135-710, Republic of Korea.

出版信息

Eur J Radiol. 2015 Nov;84(11):2089-96. doi: 10.1016/j.ejrad.2015.08.007. Epub 2015 Aug 20.

DOI:10.1016/j.ejrad.2015.08.007
PMID:26318820
Abstract

PURPOSE

To compare computed tomography (CT) findings in patients with pancreatic metastasis from renal cell carcinoma (pRCC) and patients with hypervascular pancreatic neuroendocrine tumour (pNET) with a focus on the relative percentage washout (RPW).

METHODS

We evaluated 16 patients with 37 pRCCs and 28 patients with 31 hypervascular pNETs using a protocol consisting of arterial and portal phase CT. Imaging findings were analyzed for comparison between the two groups. The RPW of each tumour using biphasic CT was obtained by two observers for evaluation of diagnostic performance. Interobserver agreement of each value and optimal cut-off level of RPW for discrimination between groups were evaluated.

RESULTS

Tumour multiplicity showed significant difference in both groups. The mean RPW of the pRCC group (observer 1, 27.0%; observer 2, 29.4%) was significantly higher than that of the pNET group (observer 1, 0.5%; observer 2, 3.2%) (p<0.001 for each observer). Interobserver agreement for both attenuation values and RPWs was excellent. A RPW value of 19% was selected as the optimal cut-off for pRCC determination, and showed good performance (accuracy 83.8%, sensitivity 83.8%, and specificity 83.9%).

CONCLUSION

With multiplicity, RPW of the tumour on CT could be helpful for differentiating pRCCs from hypervascular pNETs.

摘要

目的

比较肾细胞癌胰腺转移(pRCC)患者与富血供胰腺神经内分泌肿瘤(pNET)患者的计算机断层扫描(CT)表现,重点关注相对百分比洗脱(RPW)。

方法

我们采用动脉期和门静脉期CT方案评估了16例患有37个pRCC的患者和28例患有31个富血供pNET的患者。分析影像学表现以比较两组之间的差异。由两名观察者通过双期CT获得每个肿瘤的RPW,以评估诊断性能。评估每个值的观察者间一致性以及用于区分两组的RPW的最佳截断水平。

结果

两组肿瘤的多发性均有显著差异。pRCC组的平均RPW(观察者1为27.0%;观察者2为29.4%)显著高于pNET组(观察者1为0.5%;观察者2为3.2%)(每位观察者的p<0.001)。衰减值和RPW的观察者间一致性均极佳。选择19%的RPW值作为pRCC判定的最佳截断值,其表现良好(准确率83.8%,敏感性83.8%,特异性83.9%)。

结论

结合肿瘤的多发性,CT上肿瘤的RPW有助于鉴别pRCC和富血供pNET。

相似文献

1
Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.肾细胞癌胰腺转移瘤与富血供神经内分泌肿瘤的鉴别:相对百分比洗脱值的应用及其临床意义。
Eur J Radiol. 2015 Nov;84(11):2089-96. doi: 10.1016/j.ejrad.2015.08.007. Epub 2015 Aug 20.
2
Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.使用定性和定量特征对 CT 上的胰腺神经内分泌肿瘤和胰腺肾细胞癌转移进行区分。
Abdom Radiol (NY). 2019 Mar;44(3):992-999. doi: 10.1007/s00261-018-01889-x.
3
Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.使用增强 CT 鉴别非富血供胰腺神经内分泌肿瘤和肿块型胰腺炎。
Acta Radiol. 2021 Feb;62(2):190-197. doi: 10.1177/0284185120921503. Epub 2020 May 6.
4
Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.胰腺神经内分泌肿瘤的 CT 增强纹理分析:与 WHO 分级的相关性。
Abdom Radiol (NY). 2019 Feb;44(2):576-585. doi: 10.1007/s00261-018-1763-1.
5
Pancreatic metastasis of renal cell carcinoma: multidetector CT findings.肾细胞癌的胰腺转移:多排CT表现
Abdom Imaging. 2009 May-Jun;34(3):385-9. doi: 10.1007/s00261-008-9391-9.
6
Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.胰腺神经内分泌肿瘤患者的对比增强多层螺旋CT:与组织学结果的相关性及肿瘤分级鉴别诊断性能
Clin Radiol. 2017 Feb;72(2):150-158. doi: 10.1016/j.crad.2016.10.021. Epub 2016 Nov 24.
7
Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.胰腺内副脾与胰腺小的富血管神经内分泌肿瘤的鉴别:对比增强计算机断层扫描的纹理分析
Acta Radiol. 2019 May;60(5):553-560. doi: 10.1177/0284185118788895. Epub 2018 Aug 7.
8
Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.使用增强 CT 鉴别十二指肠胃肠道间质瘤和胰头富血供胰腺神经内分泌肿瘤。
Abdom Radiol (NY). 2019 Mar;44(3):867-876. doi: 10.1007/s00261-018-1803-x.
9
Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.动态对比增强计算机断层扫描中含等密度或低密度区域的胰腺神经内分泌肿瘤:影像表现谱及病理分级
Eur J Radiol. 2015 Nov;84(11):2103-9. doi: 10.1016/j.ejrad.2015.08.014. Epub 2015 Aug 22.
10
Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.评价肾细胞癌和肝细胞癌的肾上腺转移:使用延迟对比增强 CT。
Radiology. 2013 Feb;266(2):514-20. doi: 10.1148/radiol.12120110. Epub 2012 Nov 14.

引用本文的文献

1
Advancements in Radiomics-Based AI for Pancreatic Ductal Adenocarcinoma.基于放射组学的人工智能在胰腺导管腺癌中的进展。
Bioengineering (Basel). 2025 Aug 6;12(8):849. doi: 10.3390/bioengineering12080849.
2
Differentiation between renal cell carcinoma metastases to the pancreas and pancreatic neuroendocrine tumors in patients with renal cell carcinoma on CT or MRI.肾细胞癌患者中,通过CT或MRI鉴别肾细胞癌转移至胰腺与胰腺神经内分泌肿瘤。
Abdom Radiol (NY). 2025 Jan 7. doi: 10.1007/s00261-024-04787-7.
3
Metastatic Renal Cell Carcinoma to Pancreas: Case Series and Review of the Literature.
胰腺转移性肾细胞癌:病例系列及文献综述
Diagnostics (Basel). 2023 Apr 7;13(8):1368. doi: 10.3390/diagnostics13081368.
4
Misdiagnosis of pancreatic metastasis from renal cell carcinoma: A case report.肾细胞癌胰腺转移误诊1例报告
World J Clin Cases. 2022 Sep 6;10(25):9012-9019. doi: 10.12998/wjcc.v10.i25.9012.
5
Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma.CT鉴别胰腺实质转移瘤与胰腺导管腺癌的效用
Cancers (Basel). 2021 Jun 22;13(13):3103. doi: 10.3390/cancers13133103.
6
A case of hypervascular tumors in the liver and pancreas: synchronous hepatocellular carcinoma and pancreatic metastasis from renal cell carcinoma 36 years after nephrectomy.一例肝脏和胰腺的富血管肿瘤:肾切除术后36年出现的同步性肝细胞癌和肾细胞癌胰腺转移。
Clin Case Rep. 2020 Dec 25;9(2):932-937. doi: 10.1002/ccr3.3691. eCollection 2021 Feb.
7
CT and MRI of pancreatic tumors: an update in the era of radiomics.胰腺肿瘤的 CT 和 MRI:放射组学时代的新进展。
Jpn J Radiol. 2020 Dec;38(12):1111-1124. doi: 10.1007/s11604-020-01057-6. Epub 2020 Oct 21.
8
Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.局部晚期和转移性肾细胞癌的诊断和反应评估中的当前挑战。
Radiographics. 2019 Jul-Aug;39(4):998-1016. doi: 10.1148/rg.2019180178. Epub 2019 Jun 14.
9
Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China.中国一大学中心切除胰腺转移性肾细胞癌:经验和长期生存结果。
Int J Clin Oncol. 2019 Jun;24(6):686-693. doi: 10.1007/s10147-019-01399-w. Epub 2019 Mar 7.
10
Laparoscopic pancreaticoduodenectomy for metastatic pancreatic melanoma: A case report.腹腔镜下转移性胰腺黑色素瘤胰十二指肠切除术:一例报告
Medicine (Baltimore). 2018 Nov;97(44):e12940. doi: 10.1097/MD.0000000000012940.